The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 550.00
Bid: 547.00
Ask: 550.00
Change: 6.00 (1.10%)
Spread: 3.00 (0.548%)
Open: 540.00
High: 550.00
Low: 538.00
Prev. Close: 544.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

29 Jul 2020 07:00

RNS Number : 3915U
Polar Capital Holdings PLC
29 July 2020
 

29 July 2020

Polar Capital Holdings PLC (the "Company")

Result of AGM held on 28 July 2020

 

Legal Entity Identifier: 549300OXX7YE1947B825

Polar Capital Holdings plc is pleased to announce that all the resolutions proposed at its annual general meeting ("AGM") held at 2.30 pm on 28 July 2020 were passed on a poll.

The following table indicates the number of valid proxy votes lodged in advance of the meeting for each of the resolutions. Votes withheld do not constitute votes in law and are not counted in the number of votes for or against any resolution.

The total issued share capital at the date of the meeting was 98,478,952 ordinary shares with voting rights of one vote per share. A total of 59,196,697 votes were lodged on each of the undernoted resolutions.

Copies of resolutions 14,15 and 16, having been passed as special resolutions, will be submitted to Companies House.

 

All of the resolutions proposed at the Annual General Meeting are set out in the AGM Notice of Meeting which is available on the Company's website at: www.polarcapital.co.uk. There were no questions received on these resolutions prior to the meeting.

 

Mr Thomas Bartlam who had served as Chairman of the Company from 2007 to 2020 had not sought re-election and retired. Mr David Lamb has succeeded Mr Bartlam as Chairman of the Board from the end of the Meeting.

 

The Board wishes to record its appreciation for Mr Bartlam's service and guidance over the years.

 

 

Resolution

Shares For

%

Shares Against

%

Votes Withheld

1. To receive the Annual Report and Audited financial statements for the year ended 31 March 2020

59,159,756

100.00%

0

0.00%

36,941

2. To approve Directors' Remuneration Implementation Report for the year ended 31 March 2020

59,165,171

99.99%

4,112

0.01%

27,414

3. To elect David Lamb as a director

59,150,476

99.97%

17,374

0.03%

28,847

4. To elect Andrew Ross as a director

58,991,840

99.70%

176,010

0.30%

28,847

5. To re-elect Gavin Rochussen as a director

59,143,256

99.96%

24,594

0.04%

28,847

6. To re-elect John Mansell as a director

59,140,013

99.95%

27,837

0.05%

28,847

7. To re-elect Brian Ashford-Russell as a director

59,140,013

99.95%

27,837

0.05%

28,847

8. To re-elect Jamie Cayzer Colvin as a director

58,965,013

99.66%

202,837

0.34%

28,847

9. To re-elect Alexa Coates as a director

59,165,139

100.00%

2,711

0.00%

28,847

10. To re-elect Win Robbins as a director

59,165,139

99.99%

3,120

0.01%

28,438

11. To appoint PricewaterhouseCoopers LLP as Auditors

59,164,097

99.99%

5,307

0.01%

27,293

12. To authorise the Directors to determine the auditors' remuneration

59,143,528

99.95%

27,760

0.05%

25,409

13. To allot shares

59,162,020

99.99%

8,738

0.01%

25,939

14. To disapply pre-emption rights

59,153,740

99.98%

11,031

0.02%

31,926

15. To authorise the Company to buy-back its own shares

59,138,521

99.98%

11,554

0.02%

46,622

16. To adopt new Articles of Association

59,151,192

100.00%

1,894

0.00%

43,611

17. To increase aggregate cap on Directors fees in the Articles of Association

59,079,195

99.88%

69,682

0.12%

47,820

 

 

 Enquiries:

 

Neil Taylor

Company Secretary

+44 (0)20 7227 2700

END

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGKKFBDOBKDOOB
Date   Source Headline
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.